These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 10850303)

  • 21. Impact of IUdR on Rat 9L glioma cell survival for 25-35 keV photon-activated auger electron therapy.
    Alvarez D; Hogstrom KR; Brown TA; Ii KL; Dugas JP; Ham K; Varnes ME
    Radiat Res; 2014 Dec; 182(6):607-17. PubMed ID: 25409122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiosensitization of malignant gliomas following intracranial delivery of paclitaxel biodegradable polymer microspheres.
    Gabikian P; Tyler BM; Zhang I; Li KW; Brem H; Walter KA
    J Neurosurg; 2014 May; 120(5):1078-85. PubMed ID: 24605841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat.
    Olivi A; Ewend MG; Utsuki T; Tyler B; Domb AJ; Brat DJ; Brem H
    Cancer Chemother Pharmacol; 1996; 39(1-2):90-6. PubMed ID: 8995504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model.
    Brem S; Tyler B; Li K; Pradilla G; Legnani F; Caplan J; Brem H
    Cancer Chemother Pharmacol; 2007 Oct; 60(5):643-50. PubMed ID: 17256133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PET imaging drug distribution after intratumoral injection: the case for (124)I-iododeoxyuridine in malignant gliomas.
    Roelcke U; Hausmann O; Merlo A; Missimer J; Maguire RP; Freitag P; Radü EW; Weinreich R; Gratzl O; Leenders KL
    J Nucl Med; 2002 Nov; 43(11):1444-51. PubMed ID: 12411546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors.
    Sampath P; Hanes J; DiMeco F; Tyler BM; Brat D; Pardoll DM; Brem H
    Cancer Res; 1999 May; 59(9):2107-14. PubMed ID: 10232596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models.
    Ewend MG; Williams JA; Tabassi K; Tyler BM; Babel KM; Anderson RC; Pinn ML; Brat DJ; Brem H
    Cancer Res; 1996 Nov; 56(22):5217-23. PubMed ID: 8912860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of intracranial rat glioma model with implant of radiosensitizer and biomodulator drug combined with external beam radiotherapy.
    Li Y; Owusu A; Lehnert S
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):519-27. PubMed ID: 14751523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential radiosensitization in DNA mismatch repair-proficient and -deficient human colon cancer xenografts with 5-iodo-2-pyrimidinone-2'-deoxyribose.
    Seo Y; Yan T; Schupp JE; Colussi V; Taylor KL; Kinsella TJ
    Clin Cancer Res; 2004 Nov; 10(22):7520-8. PubMed ID: 15569982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model.
    Mairs RJ; Wideman CL; Angerson WJ; Whateley TL; Reza MS; Reeves JR; Robertson LM; Neshasteh-Riz A; Rampling R; Owens J; Allan D; Graham DI
    Br J Cancer; 2000 Jan; 82(1):74-80. PubMed ID: 10638969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iodo-2'-deoxyuridine (IUdR) and 125IUdR loaded biodegradable microspheres for controlled delivery to the brain.
    Reza MS; Whateley TL
    J Microencapsul; 1998; 15(6):789-801. PubMed ID: 9818956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracerebral delivery of 5-iodo-2'-deoxyuridine in combination with synchrotron stereotactic radiation for the therapy of the F98 glioma.
    Rousseau J; Adam JF; Deman P; Wu TD; Guerquin-Kern JL; Gouget B; Barth RF; Estève F; Elleaume H
    J Synchrotron Radiat; 2009 Jul; 16(Pt 4):573-81. PubMed ID: 19535873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy.
    Wu MP; Tamada JA; Brem H; Langer R
    J Biomed Mater Res; 1994 Mar; 28(3):387-95. PubMed ID: 8077254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a magnetic nano-graphene oxide carrier for improved glioma-targeted drug delivery and imaging: In vitro and in vivo evaluations.
    Shirvalilou S; Khoei S; Khoee S; Raoufi NJ; Karimi MR; Shakeri-Zadeh A
    Chem Biol Interact; 2018 Nov; 295():97-108. PubMed ID: 30170108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local delivery of angiogenesis-inhibitor minocycline combined with radiotherapy and oral temozolomide chemotherapy in 9L glioma.
    Bow H; Hwang LS; Schildhaus N; Xing J; Murray L; Salditch Q; Ye X; Zhang Y; Weingart J; Brem H; Tyler B
    J Neurosurg; 2014 Mar; 120(3):662-9. PubMed ID: 24359008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local delivery of chemotherapy prolongs survival in experimental brain metastases from breast carcinoma.
    Ewend MG; Sampath P; Williams JA; Tyler BM; Brem H
    Neurosurgery; 1998 Nov; 43(5):1185-93. PubMed ID: 9802862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lactacystin exhibits potent anti-tumor activity in an animal model of malignant glioma when administered via controlled-release polymers.
    Legnani FG; Pradilla G; Thai QA; Fiorindi A; Recinos PF; Tyler BM; Gaini SM; DiMeco F; Brem H; Olivi A
    J Neurooncol; 2006 May; 77(3):225-32. PubMed ID: 16609837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local delivery of minocycline and systemic BCNU have synergistic activity in the treatment of intracranial glioma.
    Frazier JL; Wang PP; Case D; Tyler BM; Pradilla G; Weingart JD; Brem H
    J Neurooncol; 2003 Sep; 64(3):203-9. PubMed ID: 14558595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-Iodo-2-deoxyuridine administered into the lateral cerebral ventricle as a radiosensitizer in the treatment of disseminated glioma.
    Deutsch M; Rewers AB; Redgate ES; Fisher ER; Boggs SS
    J Natl Cancer Inst; 1989 Sep; 81(17):1322-5. PubMed ID: 2769785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interstitial docetaxel (taxotere), carmustine and combined interstitial therapy: a novel treatment for experimental malignant glioma.
    Sampath P; Rhines LD; DiMeco F; Tyler BM; Park MC; Brem H
    J Neurooncol; 2006 Oct; 80(1):9-17. PubMed ID: 16636748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.